Abstract:Since the discovery of Stimulator of Interferon Genes (STING) as an important pivot for cytosolic DNA sensation and interferon (IFN) induction, intensive efforts have been endeavored to clarify the molecular mechanism of its activation, its physiological function as a ubiquitously expressed protein, and to explore its potential as a therapeutic target in a wide range of immune-related diseases. With its orthodox ligand 2'3'-cyclic GMP–AMP (2'3'-cGAMP) and the upstream sensor 2'3'-cGAMP synthase (cGAS) to be found, STING acquires its central functionality in the best-studied signaling cascade, namely the cGAS–STING–IFN pathway. However, recently updated research through structural research, genetic screening, and biochemical assay greatly extends the current knowledge of STING biology. A second ligand pocket was recently discovered in the transmembrane domain for a synthetic agonist. On its downstream outputs, accumulating studies sketch primordial and multifaceted roles of STING beyond its cytokine-inducing function, such as autophagy, cell death, metabolic modulation, endoplasmic reticulum (ER) stress, and RNA virus restriction. Furthermore, with the expansion of the STING interactome, the details of STING trafficking also get clearer. After retrospecting the brief history of viral interference and the milestone events since the discovery of STING, we present a vivid panorama of STING biology taking into account the details of the biochemical assay and structural information, especially its versatile outputs and functions beyond IFN induction. We also summarize the roles of STING in the pathogenesis of various diseases and highlight the development of small-molecular compounds targeting STING for disease treatment in combination with the latest research. Finally, we discuss the open questions imperative to answer.

Research progress on stimulator of interferon genes activation and its involvement in the mechanism of chronic pain

Progress in innate immunity signaling molecule STING

Mechanism and effects of STING-IFN-I pathway on nociception: A narrative review.

Induction of antiviral interferon-stimulated genes by neuronal STING promotes the resolution of pain in mice

STING/NF-κB/IL-6-Mediated Inflammation in Microglia Contributes to Spared Nerve Injury (SNI)-Induced Pain Initiation

The bidirectional roles of the cGAS-STING pathway in pain processing: Cellular and molecular mechanisms

Potential Therapeutic Value of the STING Inhibitors

What role of the cGAS-STING pathway plays in chronic pain?

Structural Insights into a Shared Mechanism of Human STING Activation by a Potent Agonist and an Autoimmune Disease-Associated Mutation.

STING controls opioid-induced itch and chronic itch via spinal tank-binding kinase 1-dependent type I interferon response in mice

Activation of the STING Pathway Induces Peripheral Sensitization Via Neuroinflammation in a Rat Model of Bone Cancer Pain.

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy

STING recognition of viral dsDNA by nociceptors mediates pain in mice

STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges

Inflammation and histone modification in chronic pain

Activation of mitochondrial DNA-mediated cGAS-STING pathway contributes to chronic postsurgical pain by inducing type I interferons and A1 reactive astrocytes in the spinal cord

STING Contributes to Cancer-Induced Bone Pain by Promoting M1 Polarization of Microglia in the Medial Prefrontal Cortex

An updated patent review of stimulator of interferon genes agonists (2021 – present)

STING, a promising target for small molecular immune modulator: A review

A TRPV4-dependent Neuroimmune Axis in the Spinal Cord Promotes Neuropathic Pain

Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020)